Opinions
Jim Cramer - Mad Money
Cytokinetics
CYTK-Q
PARTIAL SELL
Jan 08, 2024
N/A
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Shares have soared lately on rumours that Novartis will by them out. Sell half your holding and let the rest run.